Allostasis As a Conceptual Framework Linking Bipolar Disorder and Addiction
Overview
Authors
Affiliations
Bipolar disorders (BDs) and addictions constitute reciprocal risk factors and are best considered under a unitary perspective. The concepts of allostasis and allostatic load (AL) may contribute to the understanding of the complex relationships between BD and addictive behaviors. Allostasis entails the safeguarding of reward function stability by recruitment of changes in the reward and stress system neurocircuitry and it may help to elucidate neurobiological underpinnings of vulnerability to addiction in BD patients. Conceptualizing BD as an illness involving the cumulative build-up of allostatic states, we hypothesize a progressive dysregulation of reward circuits clinically expressed as negative affective states (i.e., anhedonia). Such negative affective states may render BD patients more vulnerable to drug addiction, fostering a very rapid transition from occasional drug use to addiction, through mechanisms of negative reinforcement. The resulting addictive behavior-related ALs, in turn, may contribute to illness progression. This framework could have a heuristic value to enhance research on pathophysiology and treatment of BD and addiction comorbidity.
Bipolar spectrum disorders in neurologic disorders.
Digiovanni A, Ajdinaj P, Russo M, Sensi S, Onofrj M, Thomas A Front Psychiatry. 2023; 13:1046471.
PMID: 36620667 PMC: 9811836. DOI: 10.3389/fpsyt.2022.1046471.
Winds K, Aebi M, Plattner B Child Psychiatry Hum Dev. 2022; 55(2):497-509.
PMID: 36070055 PMC: 10891233. DOI: 10.1007/s10578-022-01408-6.
Reducing Addiction in Bipolar Disorder via Hacking the Dopaminergic System.
Grunze H, Csehi R, Born C, Barabassy A Front Psychiatry. 2021; 12:803208.
PMID: 34970175 PMC: 8712474. DOI: 10.3389/fpsyt.2021.803208.
Rogers J, Epstein D, Phillips K, Strickland J, Preston K Front Psychiatry. 2021; 12:630195.
PMID: 34408672 PMC: 8367194. DOI: 10.3389/fpsyt.2021.630195.
Pettorruso M, Di Giannantonio M, De Risio L, Martinotti G, Koob G J Addict Med. 2019; 14(4):272-274.
PMID: 31725426 PMC: 7214123. DOI: 10.1097/ADM.0000000000000575.